Skip to main content
. Author manuscript; available in PMC: 2015 May 26.
Published in final edited form as: Methods Mol Biol. 2009;535:59–78. doi: 10.1007/978-1-59745-557-2_5

Fig. 5.3.

Fig. 5.3

Mechanism of aptamer–siRNA chimera-mediated targeting and silencing. Target specificity by the RNA chimera can be achieved both at level of the aptamer (PMSA-specific) as well as at the level of the siRNA (by silencing cancer cell-specific survival factors). This approach leads to selective killing of cancer cells that express both the cell surface receptor PSMA and prostate cancer-specific survival factors (e.g. Plk1 and Bcl2).